Aimed Alliance Calls for Changes to Maryland’s PDAB Action Plan
On October 18, 2024, Aimed Alliance sent a letter to the Maryland Legislative Policy Committee, urging it to make major…
Browsing: Drug Pricing: Resources
Aimed Alliance Submits Feedback on Proposed Changes to Colorado PDAB Rules
On October 16, 2024, Aimed Alliance submitted a comment to Colorado’s PDAB regarding proposed changes to its Drug Affordability Review…
Aimed Alliance Releases New 2024 PDAB Resources
Aimed Alliance is pleased to share three new resources on prescription drug affordability boards (PDABs). PDABs are established at the…
Maryland PDAB Approves UPL Action Plan and Updated Cost Review Regulations
At its September 10th meeting, the Maryland Prescription Drug Affordability Board (PDAB) approved its upper payment limit (UPL) action plan…
Colorado PDAB’s September Meeting: Updates on Affordability Review and UPL Rulemaking
On September 6, 2024, the Colorado Prescription Drug Affordability Board (PDAB) and Prescription Drug Affordability Council (PDAC) convened to discuss…
Aimed Alliance Urges CT Governor to Consider PDAB Alternatives
On August 27, 2024, Aimed Alliance sent Connecticut Governor Ned Lamont a letter urging the Governor to consider alternatives to…
Aimed Alliance Publishes New Resource on PDAB & IRA Implications for Rare Disorders
On August 20, 2024, Aimed Alliance released a new fact sheet on, “IRA, PDABs, & Orphan Drugs: How Price Setting…
Colorado PDAB Calls for Strengthening Consumer Input
Colorado’s Prescription Drug Affordability Board (PDAB) has issued recommendations to the state legislature aimed at enhancing consumer involvement, adjusting eligibility…
New White Paper Explains Why AFP Savings May Fall Short of Expectations
A new White Paper titled “Pharmacy Benefit Alternative Funding Programs: Key Considerations for Self-Funded Plan Sponsors” details how the saving…
FTC Report Unveils PBM Impact on Drug Costs and Accessibility
On July 9, 2024, the Federal Trade Commission (FTC) released an interim report highlighting the significant impact of pharmacy benefit…